Literature DB >> 7983009

A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene.

A Tugores1, S T Magness, D A Brenner.   

Abstract

We have isolated and characterized the 5'-flanking region of the gene for human ferrochelatase (HFC), the last enzyme of the heme biosynthetic pathway. The proximal promoter of the gene is contained within a region that structurally resembles a CpG island and is devoid of general cis elements such as TATA and CAAT boxes. Recognition sites for the ubiquitous Sp1 family of transcription factors, as well as for the erythroid-specific trans-acting factors NF-E2 and GATA-1 were found, and binding of regulatory proteins to these elements was analyzed by in vitro DNase I protection assays. The contribution of the various cis elements to both ubiquitous and erythroid preferential expression of the HFC gene was assessed by using transient transfection assays. These showed that a minimal Sp1-driven promoter devoid of the upstream erythroid-specific elements was sufficient for erythroid preferential expression of the HFC gene. However, elimination of a repressor sequence lying between the minimal promoter and the erythroid-specific elements resulted in high levels of expression in human erythroleukemic K562 cells only when the cis elements recognized by GATA-1 and NF-E2 were present, suggesting that the activity of these factors is regulated by a downstream repressor in erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983009

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  FKLF, a novel Krüppel-like factor that activates human embryonic and fetal beta-like globin genes.

Authors:  H Asano; X S Li; G Stamatoyannopoulos
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Genetic regulation of delta-aminolevulinate dehydratase during erythropoiesis.

Authors:  T R Bishop; M W Miller; J Beall; L I Zon; P Dierks
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

Review 3.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

Review 4.  Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells.

Authors:  Jadwiga J Gasiorek; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2015-02-27       Impact factor: 9.261

5.  p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes.

Authors:  S Deveaux; S Cohen-Kaminsky; R A Shivdasani; N C Andrews; A Filipe; I Kuzniak; S H Orkin; P H Roméo; V Mignotte
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

Review 6.  One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans.

Authors:  Iqbal Hamza; Harry A Dailey
Journal:  Biochim Biophys Acta       Date:  2012-05-08

Review 7.  Zebrafish as a model system to delineate the role of heme and iron metabolism during erythropoiesis.

Authors:  Jianbing Zhang; Iqbal Hamza
Journal:  Mol Genet Metab       Date:  2018-12-24       Impact factor: 4.797

8.  GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells.

Authors:  D Seshasayee; P Gaines; D M Wojchowski
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

9.  NFE2 regulates transcription of multiple enzymes in the heme biosynthesis pathway.

Authors:  Lara Rheinemann; Thalia S Seeger; Julius Wehrle; Heike L Pahl
Journal:  Haematologica       Date:  2014-06-20       Impact factor: 9.941

10.  SOX2 is a dose-dependent regulator of retinal neural progenitor competence.

Authors:  Olena V Taranova; Scott T Magness; B Matthew Fagan; Yongqin Wu; Natalie Surzenko; Scott R Hutton; Larysa H Pevny
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.